Showing results (361-370 of 372) with videos related to

Sort By:
Pageof 38
JCO Precision Oncology|November 20, 2024
Analysis of Concordance Between Next-Generation Sequencing Assessment of Microsatellite Instability and Immunohistochemistry-Mismatch Repair From Solid TumorsRouba Ali-Fehmi, Harris Benjamin Krause, Robert T Morris, et al.
American Journal of Human Genetics|March 15, 2011
A recurrent deletion of DPY19L2 causes infertility in man by blocking sperm head elongation and acrosome formationRadu Harbuz, Raoudha Zouari, Virginie Pierre, et al.
Human Reproduction (Oxford, England)|August 14, 2012
Identification of a new recurrent aurora kinase C mutation in both European and African men with macrozoospermiaMariem Ben Khelifa, Charles Coutton, Michael G B Blum, et al.
Blood|October 7, 2025
Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemiaJennifer R Brown, Bastien Nguyen, Sai Prasad Desikan, et al.
Blood Advances|August 22, 2025
Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Follicular Lymphoma: Phase 1/2 BRUIN StudyNirav N Shah, Pier Luigi Zinzani, Michael L Wang, et al.
Blood Advances|January 16, 2026
Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Marginal Zone Lymphoma: Phase 1/2 BRUIN StudyKrish Patel, Julie M Vose, Sunita D Nasta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2022
Molecular and clinical diversity in primary central nervous system lymphomaI Hernández-Verdin, E Kirasic, K Wienand, et al.
The Lancet. Haematology|July 21, 2024
Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN studyWilliam G Wierda, Nirav N Shah, Chan Y Cheah, et al.
The New England Journal of Medicine|July 5, 2023
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic LeukemiaAnthony R Mato, Jennifer A Woyach, Jennifer R Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2023
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell LymphomaMichael L Wang, Wojciech Jurczak, Pier Luigi Zinzani, et al.
Pageof 38